Overall rank by patents
#22,733
of 50,000 tracked assignees
USPTO PatentsView assignee record - 12 granted patents across 9 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).
The verdict
According to USPTO PatentsView, Humacyte ranks #22,733 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 9 technology areas.
USPTO PatentsView assignee plate
Corpus R22733 · US Corporation #22,733 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
Nearest grant-volume peer: Hopin Ltd (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Adienne Pharma &biot… · near
31 score
Vanderbilt Chemicals · near
31 score
Humacyte · this assignee
31 score
Panoscape Holdings · near
31 score
Jasper · near
31 score
3D Lighting Innovati… · lowest
7 score
What this shows Humacyte's Innovation Score is 30.8/100 (top 64% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Humacyte, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 75% of grants classified under A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2020. By volume, Humacyte sits between Hopin Ltd and Hydraforce, Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Hopin LTD
12 patents
Hough Ear Institute
12 patents
Hughey & Phillips, LLC
12 patents
Hulkman Innovation Technology (Shenzhen) Co., Ltd.
12 patents
HumanEyes Technologies Ltd.
12 patents
Hvidovre Hospital
12 patents
Hydra Heating Industries, LLC
12 patents
HydraForce, Inc.
12 patents
Humacyte, Inc.
12 patents
What this shows Humacyte holds 12 patents at rank #22,733, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #22,733 in granted patent volume.
Other assignees with the most granted patents in Humacyte's primary technology class.
Two PlainPatent-derived peer sets for Humacyte, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (31 here).
Humacyte's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 Top 64% higher than 36% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 3 | 25.0% |
| 2019 | 2 | 16.7% |
| 2020 | 1 | 8.3% |
| 2021 | 3 | 25.0% |
| 2024 | 2 | 16.7% |
| 2025partial year | 1 | 8.3% |
Top 9 of 9 technology areas
Overall rank by patents
#22,733
of 50,000 tracked assignees
30.8 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.